Journal of Virology · 1993 · 495 citations · 34 references
Life SciencesBiologyPharmacologyIon Channel BiophysicsMolecular VirologyVirologyChannel StructureIon Channel ModulationIon Channel PharmacologyIon Channel PhysiologyIon Channel RegulationIon ChannelsAmino Acid Sequence EffectsAvian Influenza VirusIon Channel ActivationIon Channel Pore ArchitectureIon Channel SelectivityIon Channel StructureIon Channel Structure-function RelationshipsTransmembrane Protein Topology
The influenza A virus M2 integral membrane protein has ion channel activity which can be blocked by the antiviral drug amantadine. The M2 protein transmembrane domain is highly conserved in amino acid sequence for all the human, swine, equine, and avian strains of influenza A virus, and thus, known amino acid differences could lead to altered properties of the M2 ion channel. We have expressed in oocytes of Xenopus laevis the M2 protein of human influenza virus A/Udorn/72 and the avian virus A/chicken/Germany/34 (fowl plague virus, Rostock) and derivatives of the Rostock ion channel altered in the presumed pore region. The pH of activation of the M2 ion channels and amantadine block of the M2 ion channels were investigated. The channels were found to be activated by pH in a similar manner but differed in their apparent Kis for amantadine block.
34
André DeLÉAN, Peter J. Munson, David Rodbard · American Journal of Physiology-Endocrinology and Metabolism · 1978 · 2.4K citations
Influenza virus M2 protein has ion channel activity
Lawrence H. Pinto, Leslie J. Holsinger, Robert A. Lamb · Cell · 1992 · 1.2K citations
The molecular basis of the specific anti‐influenza action of amantadine.
Alan Hay, Adrian J. Wolstenholme, J.J. Skehel et al. · The EMBO Journal · 1985 · 855 citations · Full text